Session 3: March 1, 2022 - 12:00 to 2:00 pm

March 1, 2022

SERIES DESCRIPTION

In this three-session online course, participants will learn about the new science on the influence of environmental chemicals on cancer. The sessions are aimed at clinicians and also will be informative for policy makers, cancer researchers, and members of the public. Clinicians will be better able to answer patient questions, and they will gain skills in engaging in population-level policy change and community-based public health initiatives.

SESSION 3 DESCRIPTION

Primary prevention and a role for clinicians as trusted communicators - barriers and opportunities.

Target Audience

This activity is intended for clinicians & care providers from across all medical specialties.

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Demonstrate skills to speak with news media on impact of environmental issues on public health and cancer.
  2. Identify misinformation targeted to the public by industrial interests.

Additional Information

Provided by: 

Dana-Farber Cancer Institute, DF/HCC Center for Cancer Equity and Engagement, Silent Spring Institute, UMass Lowell/Lowell Center for Sustainable Production, Cancer Free Economy Network & Mass General Brigham

          

                         

     

Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Nursing Contact Hours
  • 2.00 Participation
Course opens: 
11/08/2021
Course expires: 
04/01/2022
Event starts: 
03/01/2022 - 12:00pm EST
Event ends: 
03/01/2022 - 2:00pm EST
Cost:
$0.00
Part of: 
Cancer & Environment Forum 2022: What Does New Science Say About Chemicals & Cancer? Lessons from Public Health & Environmental Medicine
Add to calendar: 

March 1, 2022 | 12:00 - 2:00 PM ET

Session 3: Primary prevention and a role for clinicians as trusted communicators - barriers and opportunities.

Introduction: Forward-looking strategies to catalyze environmental cancer prevention.

  • Julia Brody, PhD - Executive Director and Senior Scientist, Silent Spring Institute

Speakers:

  • Margaret Kripke, PhD - Professor Emeritus and founding chair of the Department of Immunology at the University of Texas MD Anderson Cancer Center, Co-Panelist on the President’s Cancer Panel
    • Missed opportunities for primary prevention of environmental cancers.
  • David Michaels, PhD, MPH - George Washington University School of Public Health
    • Author of The Triumph of Doubt on the challenge of defending public health science when it is targeted by chemical and drug makers sowing doubt.
  • Ruthann Rudel, MS - Director of Research, Silent Spring Institute
    • Chemicals that increase synthesis of estrogen and progesterone as risk factors for breast cancer: A case study for 21st century approaches to identifying likely carcinogens.

Panel: What to say to your patients, policymakers, and to the news media about chemicals and cancer when the science is uncertain.

  • Moderator: Julia Brody
  • Phil Landrigan, MD - Director, Global Public Health Program, Boston College
    • Experiences of a pediatrician giving everyday advice and also speaking publicly about potential causes of cancer and other diseases without blaming patients.
  • Amy Kostant, MA -  Executive Director, Science Communication Network
    • Practical guidance for scientists and clinicians to advance public understanding via the news media.
  • Gary Ellison, PhD, MPH - National Institute of Environmental Health Sciences and National Cancer Institute
    • New cohorts and other research to integrate environmental exposure and social determinants of health to advance equity.

Closing Remarks/Reflections: The role of cancer centers in advancing environmental prevention.

See Session 1 Program
See Session 2 Program

Julia Brody, PhD
Executive Director & Senior Scientist, Silent Spring Institute
Newton, MA

Gary Ellison, PhD, MPH
Branch Chief, National Institute of Environmental Health Sciences & National Cancer Institute - Environmental Epidemiology
Bethesda, MD

Amy Kostant, MA
Executive Director, Science Communication Network
Bethesda, MD

Margaret Kripke, PhD
Professor Emeritus, and Founding Chair, University of Texas MD - Anderson Cancer Center, Department of Immunology
Houston, TX

Phil Landrigan, MD, MSc
Director, Boston College - Global Public Health Program and Global Pollution Observatory
Chestnut Hill, MA

David Michaels, PhD, MPH
Professor, George Washington University School of Public Health
Author, "Doubt is Their Product"
Washington, DC

Timothy Rebbeck, PhD
Vincent L. Gregory, Jr. Professor of Cancer Prevention
Director, Zhu Family Center for Global Cancer Prevention
Harvard T.H. Chan School of Public Health & Dana-Farber Cancer Institute 
Boston, MA

Ruthann Rudel, MS
Director of Research, Silent Spring Institute
Newton, MA

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Mass General Brigham designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit Designation Statement

2 Contact Hours of Nursing Continuing Professional Development (NCPD), will be awarded for attending each presentation in its entirety and completing an evaluation.

Approval Statement

Dana-Farber Cancer Institute is approved as a provider of nursing continuing professional development by the American Nurses Association Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Nursing Contact Hours
  • 2.00 Participation

Price

Cost:
$0.00
Please login or register to take this course.